This Month’s Focus: Devices
Technology selection in capsule-based inhalation product development
Developers must carefully evaluate the device, formulation and capsule, as well as the interactions among them.
An update on solid-state physicochemical characterization and microscopy of particles in dry powder inhalers
Inhalation is happy to republish an article from our free archive and update its content using an interview with two of the article authors.
Solid-state physicochemical characterization and microscopy of particles in dry powder inhalers
Physicochemical properties affect physical and chemical stability, and in turn, therapeutic activity and drug bioavailability.
Back Page: First comprehensive lung cell map leads to new findings and implications for asthma
Researchers found differences between normal and asthmatic airways as well as in the ways lung cells communicate and a new cell state that produces mucus in asthmatic patients.
Cross-Industry Organizations: Respiratory Drug Delivery (RDD®) Conferences focus on combination products
The article reviews RDD Europe 2019 whose plenary lecture focused on combination products, and previews both RDD 2020 (which will be followed by a symposium by IPAC-RS) and RDD Asia 2020.
A preview of AAPS PharmSci 360
The AAPS Annual Meeting, now known as PharmSci 360, will be held November 3-7, 2019 in San Antonio, TX, US.
Previewing DDL2019: The 30th Anniversary Conference
The 30th anniversary Drug Delivery to the Lungs (DDL) Conference will be held December 11-13, 2019 at the Edinburgh International Conference Centre (EICC).
Optimizing the role of automation in variability reduction strategies for inhaler testing
Quality requirements for cascade impactors assigned to batch release testing of a specific drug product: Part II: The concept of “sufficient” as applied to impactor quality specifications
Back Page: The SA Kids BREATHE Program
Cross-Industry Organizations: An introduction to the Product Quality Research Institute (PQRI)
A preview of Drug Delivery Partnerships 2020
January: Reference and Buyer’s Resource
February: Product Development/ Contract Testing
June: Nasal Delivery/Nebulizers
August: Particle Characterization
1155 Northland Drive
St. Paul, MN 55120
Inhalation Article Guidelines
Technical article requirements
The article should be technical and educational, but not promotional. It must be new, not previously published and must be at least 50% different from your previous articles or other articles you are simultaneously developing on the same subject.
All discussions of products or technologies must be in an unbiased, non-promotional, educational manner. If your article discusses products that have been commercialized or are in development, please be aware of the following: Inhalation takes a very limited approach in discussing products, usually listing only product name, delivered drug name and company name, unless a description is provided by the particular company that owns a product, such as in a case study article or product news release. In that way, each company can choose the information it wishes to discuss or disclose about its own products, rather than being discussed by an outside party with no ability to comment prior to publication. However, if an article is a case study, presentation of a novel technology or news article written by the owner company or its representative such as a scientist or consultant, we are happy to consider all information or data they wish to disclose, provided it is presented in a fair-balanced manner. Also, please avoid discussing product or development costs and do not make cost comparisons.
The article should be 2,500-3,500 words and must include at least five references or items for recommended reading.
We encourage images and/or data tables and have space for three or four of them. We’re flexible about that number so let us know if you need more image space. We also like to publish an additional photo or illustration at the beginning of the article. Images should be sent as separate files that meet the following specifications: high resolution, 300 dpi at a size of 7 x 7 inches and in only JPG, TIF or EPS formats.
Please be aware, due to copyrights, if you use figures or tables from articles that have been previously published in other journals, you must obtain permission from those journals in order to use the images. If you are an author on the published article in question, you may still need permission but there should be no fees from the other journal. If you are not an author and the other journal wants to charge you fees for usage, please contact us before proceeding. We do not want authors incurring costs in order to publish in Inhalation and there may be alternate approaches to citing information that could be used. Also, “open journals” do not charge for image use. If you have any questions or concerns, please contact us.
Editorial board review and production
All of our articles are peer-reviewed and must be accepted by our editorial board or a designated reviewer in order to be published. When you send us the article, it will go to a member of the board and we will coordinate communication between you. Once an article is accepted, we handle production and you will see the final article in layout before it goes to print or is published in the digital edition.